Reviva Pharmaceuticals (RVPH) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.89
-1.3
-0.71
-0.12

Details

Expected EPS
-0.355
Actual EPS
-0.46
Surprise EPS
-0.11
Surprise Percent
+29.58%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -0.46 per share for Q2 2026.

0 Comments

Share your thoughts